Peter B. Coggins
Director/Board Member bei BIOSEEK PLC
Profil
Peter B.
Coggins is currently the Director at BioSeek Plc since 2010.
He previously held positions as Chairman at Analytical Life Science & Diagnostics Association, Non-Executive Director at deltaDOT Ltd., Director at NIPD Genetics Ltd., and President-Life & Analytical Sciences & SVP at Revvity, Inc. From 1994 to 2002, he served as the Executive Vice President-Global Sales & Marketing at Amersham Biosciences Corp.
Dr. Coggins obtained his undergraduate and doctorate degrees from Chelsea College.
Aktive Positionen von Peter B. Coggins
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSEEK PLC | Director/Board Member | 03.04.2008 |
Ehemalige bekannte Positionen von Peter B. Coggins
| Unternehmen | Position | Ende |
|---|---|---|
| Amersham Biosciences Corp. /One Dimen Electrophoresis Bus/ | Sales & Marketing | 01.06.2002 |
NIPD Genetics Ltd.
 NIPD Genetics Ltd. BiotechnologyHealth Technology Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The private company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million. | Director/Board Member | - |
| Analytical Life Science & Diagnostics Association | Chairman | - |
deltaDOT Ltd.
 deltaDOT Ltd. Medical SpecialtiesHealth Technology deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
| REVVITY, INC. | Corporate Officer/Principal | - |
Ausbildung von Peter B. Coggins
| Chelsea College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Amersham Biosciences Corp. /One Dimen Electrophoresis Bus/ | Health Technology |
BioSeek Plc
 BioSeek Plc Miscellaneous Commercial ServicesCommercial Services BioSeek Plc provides human tissue-based research services for the pharmaceutical industry. It focuses on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals. The company was founded by Eugene Butcher in March 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
deltaDOT Ltd.
deltaDOT Ltd. Medical SpecialtiesHealth Technology deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom. | Health Technology |
NIPD Genetics Ltd.
NIPD Genetics Ltd. BiotechnologyHealth Technology Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The private company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million. | Health Technology |
| Analytical Life Science & Diagnostics Association |
